Bridging Biology to Clinical Candidates

IDDI was founded to bridge the critical gap between academic discovery and viable drug candidates. We provide open-access screening and target validation platforms, accelerating promising research into clinical pipelines.

Our model supports researchers by removing commercial friction, ensuring that groundbreaking science can advance without profit-seeking constraints. This commitment drives our mission for public health.

Trusted Voices

IDDI's open science approach has been instrumental in validating novel targets for our oncology program. Their data integrity is unmatched.

Dr. Anya Sharma, Grant Director

The governance structure at IDDI ensures complete transparency and scientific rigor, making them an ideal partner for philanthropic investment in translational medicine.

Prof. David Chen, Academic Chair

Their pre-competitive research platforms significantly accelerate our early-stage drug discovery efforts, moving promising compounds closer to patients.

Maria Rodriguez, Biotech Executive

Research & Grant Inquiries

Connect with our research directorate for proposals, platform access, or partnership opportunities. We welcome collaborations that advance open science and translational pipelines.